Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Clinical Pharmacology in Drug Development
|
November 2, 2020
Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed-Dose Combination Tablets to Canadian-Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States
Vikas Kumar Dawra, Kathleen Pelletier, Kyle Matschke, et al.
Biopharmaceutics & Drug Disposition
|
March 14, 2002
Disposition of radiolabeled BMS-204352 in rats and dogs
Rajesh Krishna, Ming Yao, Nuggehally R Srinivas, et al.
Journal of Clinical Pharmacology
|
October 1, 2010
Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development
Jeffrey D Wetherington, Marc Pfister, Christopher Banfield, et al.
British Journal of Clinical Pharmacology
|
June 26, 2009
Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
Rajesh Krishna, Amit Garg, Bo Jin, et al.
The Journal of Pharmacy and Pharmacology
|
June 25, 2002
Clearance and disposition of indometacin in chronically instrumented fetal lambs following a 3-day continuous intravenous infusion
Rajesh Krishna, K Wayne Riggs, Eddie Kwan, et al.
Journal of Biopharmaceutical Statistics
|
December 16, 2022
Use of pharmacodynamic modeling for Bayesian information borrowing in pediatric clinical trials
Bernard Sebastien, S Y Amy Cheung, Solange Corriol-Rohou, et al.
Clinical Pharmacology in Drug Development
|
April 2, 2019
Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects
Yinhua Li, Yuting Mu, Haihong Shi, et al.
Schizophrenia Research. Cognition
|
January 8, 2026
Cognitive functioning and hyperhomocysteinemia in schizophrenia
Ushasti Sinha, Shambhavi Shiva, Anirudh Rajan, et al.
Biopharmaceutics & Drug Disposition
|
October 6, 2016
Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir
Rajesh Krishna, Lilly East, Patrick Larson, et al.
Journal of Clinical Pharmacology
|
August 22, 2014
Non-obligatory role of prostaglandin D2 receptor subtype 1 in rosacea: laropiprant in comparison to a placebo did not alleviate the symptoms of erythematoelangiectaic rosacea
Rajesh Krishna, Ying Guo, Valerie Schulz, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Clinical Pharmacology in Drug Development
|
November 2, 2020
Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed-Dose Combination Tablets to Canadian-Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States
Vikas Kumar Dawra, Kathleen Pelletier, Kyle Matschke, et al.
Biopharmaceutics & Drug Disposition
|
March 14, 2002
Disposition of radiolabeled BMS-204352 in rats and dogs
Rajesh Krishna, Ming Yao, Nuggehally R Srinivas, et al.
Journal of Clinical Pharmacology
|
October 1, 2010
Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development
Jeffrey D Wetherington, Marc Pfister, Christopher Banfield, et al.
British Journal of Clinical Pharmacology
|
June 26, 2009
Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
Rajesh Krishna, Amit Garg, Bo Jin, et al.
The Journal of Pharmacy and Pharmacology
|
June 25, 2002
Clearance and disposition of indometacin in chronically instrumented fetal lambs following a 3-day continuous intravenous infusion
Rajesh Krishna, K Wayne Riggs, Eddie Kwan, et al.
Journal of Biopharmaceutical Statistics
|
December 16, 2022
Use of pharmacodynamic modeling for Bayesian information borrowing in pediatric clinical trials
Bernard Sebastien, S Y Amy Cheung, Solange Corriol-Rohou, et al.
Clinical Pharmacology in Drug Development
|
April 2, 2019
Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects
Yinhua Li, Yuting Mu, Haihong Shi, et al.
Schizophrenia Research. Cognition
|
January 8, 2026
Cognitive functioning and hyperhomocysteinemia in schizophrenia
Ushasti Sinha, Shambhavi Shiva, Anirudh Rajan, et al.
Biopharmaceutics & Drug Disposition
|
October 6, 2016
Efavirenz does not meaningfully affect the single dose pharmacokinetics of 1200 mg raltegravir
Rajesh Krishna, Lilly East, Patrick Larson, et al.
Journal of Clinical Pharmacology
|
August 22, 2014
Non-obligatory role of prostaglandin D2 receptor subtype 1 in rosacea: laropiprant in comparison to a placebo did not alleviate the symptoms of erythematoelangiectaic rosacea
Rajesh Krishna, Ying Guo, Valerie Schulz, et al.
Page
of 10